138 related articles for article (PubMed ID: 22730905)
1. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification.
Sassa N; Tsuzuki T; Fukatsu A; Majima T; Kimura T; Nishikimi T; Yoshino Y; Hattori R; Gotoh M
Histopathology; 2012 Oct; 61(4):620-8. PubMed ID: 22730905
[TBL] [Abstract][Full Text] [Related]
2. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
Sano T; Kato M; Sassa N; Sadachi R; Hirakawa A; Kamihira O; Hirabayashi T; Nishikimi T; Katsuno S; Kimura T; Hattori R; Gotoh M; Tsuzuki T
Virchows Arch; 2021 Jun; 478(6):1089-1097. PubMed ID: 33420835
[TBL] [Abstract][Full Text] [Related]
3. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
[TBL] [Abstract][Full Text] [Related]
5. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma.
Yoshimura K; Arai Y; Fujimoto H; Nishiyama H; Ogura K; Okino T; Ogawa O
Cancer; 2002 Jun; 94(12):3150-6. PubMed ID: 12115347
[TBL] [Abstract][Full Text] [Related]
7. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
8. Renal Pelvic Urothelial Carcinoma With Invasion Into Renal Medulla Can Be Redefined as pT2 to Improve Correlation With Survival.
Wong MN; Wu DJ; Lee CT; Zynger DL
Mod Pathol; 2023 Jun; 36(6):100140. PubMed ID: 36813117
[TBL] [Abstract][Full Text] [Related]
9. A proposal for a novel staging system in renal pelvicaliceal urothelial carcinomas.
Cho KS; Cho DS; Choi YD; Hong SJ; Kim SJ; Cho NH
Hum Pathol; 2007 Nov; 38(11):1639-48. PubMed ID: 17651786
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
[TBL] [Abstract][Full Text] [Related]
12. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
[TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
Holmäng S; Johansson SL
Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma.
Cho KS; Cho NH; Park SY; Cho SY; Choi YD; Chung BH; Yang SC; Hong SJ
J Korean Med Sci; 2008 Jun; 23(3):434-8. PubMed ID: 18583879
[TBL] [Abstract][Full Text] [Related]
15. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
Scosyrev E; Yao J; Messing E
Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
Zarei S; Frank I; Boorjian SA; Thompson RH; Kim S; Weight C; Tarrell R; Thapa P; Cheville JC
J Urol; 2012 Nov; 188(5):1706-11. PubMed ID: 22998911
[TBL] [Abstract][Full Text] [Related]
17. [Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma].
Bruzzi M; Le Goux C; Pignot G; Amsellem-Ouazana D; Vieillefond A; Patard JJ; Zerbib M
Prog Urol; 2014 Jul; 24(9):556-62. PubMed ID: 24975790
[TBL] [Abstract][Full Text] [Related]
18. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
[TBL] [Abstract][Full Text] [Related]
19. Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Taguchi S; Tabata M; Kaneko T; Ishikawa A; Miyazaki H; Kondo Y; Matsumoto A; Naito A; Hikatsu M; Fujii Y; Akiyama Y; Yamada Y; Sato Y; Nomiya A; Yamada D; Murata T; Suzuki M; Enomoto Y; Nishimatsu H; Takeuchi T; Tanaka Y; Kume H
World J Urol; 2023 Mar; 41(3):767-776. PubMed ID: 36739339
[TBL] [Abstract][Full Text] [Related]
20. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
